Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

PKCA S159-p , S163-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

ERK1 S46-p
ERK2 S46-p
JNK1 S46-p
JNK2 S46-p
PKACA S159-p
PKCA S159-p , S163-p , S167-p , S170-p
PKCA S163-p , S167-p
PKCA S159-p
ROCK1 S159-p
Regulatory protein:
ANXA1 S170-p
CYBA S170-p
TBK1 S170-p
Treatment:
angiotensin-(1-7) S170-p
angiotensin_2 S101-p , S128-p , S131-p , S145-p , T150-p , S159-p , S167-p , S170-p
apocynin S170-p
ATP S159-p
bombesin S159-p , S163-p
C3_toxin S159-p
dasatinib S159-p , S163-p
EGF S27-p , S81-p , S101-p , S118-p , S159-p , S167-p , S170-p
eribulin S159-p , S163-p
GF109203X S159-p , S163-p
HA-1077 S159-p
ischemia S145-p , T150-p , S163-p , S167-p , S170-p
lapatinib S101-p
LPA T120-p , S159-p
LRRK2-IN-1 S163-p , S167-p , S170-p
MANS_peptide S159-p , S163-p
metastatic potential S170-p
NAC S170-p
nocodazole S27-p , S29-p , S46-p , S77-p , S81-p , S101-p , S145-p , T150-p , S159-p , S163-p , S167-p , S170-p
phorbol_ester S159-p , S163-p
pleiotrophin S159-p , S163-p
SB202190 S167-p , S170-p
selumetinib S101-p , S118-p
taxol S159-p , S163-p
U0126 S101-p , S118-p , S170-p
vemurafenib S101-p , S118-p
vincristine S159-p , S163-p
WKYMVm S170-p